-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Harmony Biosciences Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2024.
- Harmony Biosciences Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $61.7M, a 4.34% decline year-over-year.
- Harmony Biosciences Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $175M, a 12.1% decline year-over-year.
- Harmony Biosciences Holdings, Inc. annual Operating Income (Loss) for 2023 was $192M, a 59.8% increase from 2022.
- Harmony Biosciences Holdings, Inc. annual Operating Income (Loss) for 2022 was $120M, a 37.3% increase from 2021.
- Harmony Biosciences Holdings, Inc. annual Operating Income (Loss) for 2021 was $87.5M, a 415% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)